was read the article
array:24 [ "pii" => "S2173574318300728" "issn" => "21735743" "doi" => "10.1016/j.reumae.2018.03.001" "estado" => "S300" "fechaPublicacion" => "2018-09-01" "aid" => "1226" "copyright" => "Elsevier España, S.L.U. and Sociedad Española de Reumatología y Colegio Mexicano de Reumatología" "copyrightAnyo" => "2018" "documento" => "article" "crossmark" => 1 "subdocumento" => "ssu" "cita" => "Reumatol Clin. 2018;14:294-300" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 2 "PDF" => 2 ] "Traduccion" => array:1 [ "es" => array:19 [ "pii" => "S1699258X18300949" "issn" => "1699258X" "doi" => "10.1016/j.reuma.2018.03.012" "estado" => "S300" "fechaPublicacion" => "2018-09-01" "aid" => "1226" "copyright" => "Sociedad Española de Reumatología y Colegio Mexicano de Reumatología" "documento" => "article" "crossmark" => 1 "subdocumento" => "ssu" "cita" => "Reumatol Clin. 2018;14:294-300" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 14045 "formatos" => array:3 [ "EPUB" => 113 "HTML" => 12192 "PDF" => 1740 ] ] "es" => array:13 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Revisión</span>" "titulo" => "Manifestaciones pulmonares en lupus eritematoso sistémico: afección pleural, neumonitis aguda, enfermedad intersticial crónica y hemorragia alveolar difusa" "tienePdf" => "es" "tieneTextoCompleto" => "es" "tieneResumen" => array:2 [ 0 => "es" 1 => "en" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "294" "paginaFinal" => "300" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Pulmonary manifestations in systemic lupus erythematosus: pleural involvement, acute pneumonitis, chronic interstitial lung disease and diffuse alveolar hemorrhage" ] ] "contieneResumen" => array:2 [ "es" => true "en" => true ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0015" "etiqueta" => "Figura 3" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr3.jpeg" "Alto" => 774 "Ancho" => 750 "Tamanyo" => 57639 ] ] "descripcion" => array:1 [ "es" => "<p id="spar0025" class="elsevierStyleSimplePara elsevierViewall">Hombre de 22 años con hermano gemelo con lupus eritematoso sistémico, ambos con datos de síndrome de Schnitzler (cuadros intermitentes de fiebre, urticaria, dolor abdominal, angioedema, artritis), en los últimos 2 meses con disnea progresiva hasta la de mínimos, poliartritis, hipertensión, edema mecánico y en los días precedentes tos e incremento de disnea. A la exploración, con complejo de la pulmonar de Chávez y síndrome de condensación basal derecho; radiografía con datos de hipertensión pulmonar, 4 arcos, neumonitis basal derecha y derrame homolateral. Se realizó diagnóstico de neumonitis lúpica que se manejó con prednisona 0,5<span class="elsevierStyleHsp" style=""></span>mg/kg/día y ciclofosfamida con adecuada respuesta.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Georgina Aguilera-Pickens, Carlos Abud-Mendoza" "autores" => array:2 [ 0 => array:2 [ "nombre" => "Georgina" "apellidos" => "Aguilera-Pickens" ] 1 => array:2 [ "nombre" => "Carlos" "apellidos" => "Abud-Mendoza" ] ] ] ] ] "idiomaDefecto" => "es" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S2173574318300728" "doi" => "10.1016/j.reumae.2018.03.001" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173574318300728?idApp=UINPBA00004M" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1699258X18300949?idApp=UINPBA00004M" "url" => "/1699258X/0000001400000005/v1_201809090415/S1699258X18300949/v1_201809090415/es/main.assets" ] ] "itemSiguiente" => array:19 [ "pii" => "S2173574318300789" "issn" => "21735743" "doi" => "10.1016/j.reumae.2017.01.014" "estado" => "S300" "fechaPublicacion" => "2018-09-01" "aid" => "1014" "copyright" => "Elsevier España, S.L.U. and Sociedad Española de Reumatología y Colegio Mexicano de Reumatología" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "crp" "cita" => "Reumatol Clin. 2018;14:301-2" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 3 "formatos" => array:2 [ "HTML" => 1 "PDF" => 2 ] ] "en" => array:12 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Case Report</span>" "titulo" => "Septic Arthritis in a Native Knee Due to <span class="elsevierStyleItalic">Corynebacterium striatum</span>" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => array:2 [ 0 => "en" 1 => "es" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "301" "paginaFinal" => "302" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Artritis séptica de rodilla nativa por <span class="elsevierStyleItalic">Corynebacterium striatum</span>" ] ] "contieneResumen" => array:2 [ "en" => true "es" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Juan Molina Collada, Alicia Rico Nieto, Macarena Díaz de Bustamante Ussia, Alejandro Balsa Criado" "autores" => array:4 [ 0 => array:2 [ "nombre" => "Juan" "apellidos" => "Molina Collada" ] 1 => array:2 [ "nombre" => "Alicia" "apellidos" => "Rico Nieto" ] 2 => array:2 [ "nombre" => "Macarena" "apellidos" => "Díaz de Bustamante Ussia" ] 3 => array:2 [ "nombre" => "Alejandro" "apellidos" => "Balsa Criado" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S1699258X17300335" "doi" => "10.1016/j.reuma.2017.01.013" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1699258X17300335?idApp=UINPBA00004M" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173574318300789?idApp=UINPBA00004M" "url" => "/21735743/0000001400000005/v1_201810010939/S2173574318300789/v1_201810010939/en/main.assets" ] "itemAnterior" => array:19 [ "pii" => "S2173574318300893" "issn" => "21735743" "doi" => "10.1016/j.reumae.2017.03.010" "estado" => "S300" "fechaPublicacion" => "2018-09-01" "aid" => "1038" "copyright" => "Elsevier España, S.L.U. and Sociedad Española de Reumatología y Colegio Mexicano de Reumatología" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "crp" "cita" => "Reumatol Clin. 2018;14:290-3" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 5 "formatos" => array:2 [ "HTML" => 3 "PDF" => 2 ] ] "en" => array:12 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Brief Report</span>" "titulo" => "Heel Pain in Psoriatic Arthropathy: Analysis of a Series of 291 Patients" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => array:2 [ 0 => "en" 1 => "es" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "290" "paginaFinal" => "293" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "La talalgia en la artropatía psoriásica. Análisis de una serie de 291 pacientes" ] ] "contieneResumen" => array:2 [ "en" => true "es" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Isabel Morales Ivorra, Pablo Juárez López, Mercè López de Recalde, Pedro David Carvalho, Jesus Rodriguez Moreno" "autores" => array:5 [ 0 => array:2 [ "nombre" => "Isabel" "apellidos" => "Morales Ivorra" ] 1 => array:2 [ "nombre" => "Pablo" "apellidos" => "Juárez López" ] 2 => array:2 [ "nombre" => "Mercè" "apellidos" => "López de Recalde" ] 3 => array:2 [ "nombre" => "Pedro David" "apellidos" => "Carvalho" ] 4 => array:2 [ "nombre" => "Jesus" "apellidos" => "Rodriguez Moreno" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S1699258X17300657" "doi" => "10.1016/j.reuma.2017.03.010" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1699258X17300657?idApp=UINPBA00004M" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173574318300893?idApp=UINPBA00004M" "url" => "/21735743/0000001400000005/v1_201810010939/S2173574318300893/v1_201810010939/en/main.assets" ] "en" => array:20 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Review Article</span>" "titulo" => "<span class="elsevierStyleBold">Pulmonary Manifestations in Systemic Lupus Erythematosus: Pleural Involvement, Acute Pneumonitis, Chronic Interstitial Lung Disease and Diffuse Alveolar Hemorrhage</span>" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "294" "paginaFinal" => "300" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "Georgina Aguilera-Pickens, Carlos Abud-Mendoza" "autores" => array:2 [ 0 => array:2 [ "nombre" => "Georgina" "apellidos" => "Aguilera-Pickens" ] 1 => array:4 [ "nombre" => "Carlos" "apellidos" => "Abud-Mendoza" "email" => array:1 [ 0 => "c_abud@hotmail.com" ] "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">*</span>" "identificador" => "cor0005" ] ] ] ] "afiliaciones" => array:1 [ 0 => array:2 [ "entidad" => "Unidad de Investigaciones Reumatológicas, Facultad de Medicina, Universidad Autónoma de San Luis Potosí y Hospital Central Dr. Ignacio Morones Prieto, San Luis Potosí, Mexico" "identificador" => "aff0005" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "Corresponding author." ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Manifestaciones pulmonares en lupus eritematoso sistémico: afección pleural, neumonitis aguda, enfermedad intersticial crónica y hemorragia alveolar difusa" ] ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0015" "etiqueta" => "Fig. 3" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr3.jpeg" "Alto" => 774 "Ancho" => 750 "Tamanyo" => 57844 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0025" class="elsevierStyleSimplePara elsevierViewall">A 22-year-old man with a twin brother with systemic lupus erythematosus. Both showed evidence of Schnitzler syndrome (intermittent episodes of fever, urticaria, abdominal pain, angioedema, arthritis). He had a 2-month history of progressive dyspnea even on minimum exertion, polyarthritis, hypertension, mechanical edema and, on the preceding days, cough and increased dyspnea. Exploration revealed Chávez’ pulmonary complex and right basal condensation syndrome; radiograph showing evidence of pulmonary hypertension, 4 arches, right basal pneumonitis and homolateral effusion. He was diagnosed with lupus pneumonitis, which was managed with prednisone at 0.5<span class="elsevierStyleHsp" style=""></span>mg/kg body weight/day and cyclophosphamide, with a satisfactory response.</p>" ] ] ] "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">Systemic lupus erythematosus (SLE) is the autoimmune disease with the highest prevalence of pulmonary involvement, which ranges from 20% to 90% of the patients, depending on the criteria employed in the cohorts being studied (symptomatology or histopathology).<a class="elsevierStyleCrossRefs" href="#bib0435"><span class="elsevierStyleSup">1,2</span></a> More than 50% of the patients develop pleuropulmonary manifestations at least once during the course of the disease; likewise, pleuropulmonary involvement has been associated with a higher rate of mortality.<a class="elsevierStyleCrossRef" href="#bib0445"><span class="elsevierStyleSup">3</span></a> Symptoms such as pleuritic pain, cough and/or dyspnea are usually the first signs of SLE-related pulmonary involvement, or can be the first manifestation of SLE. Up to 60%<a class="elsevierStyleCrossRef" href="#bib0450"><span class="elsevierStyleSup">4</span></a> of the patients have reported dyspnea at least once throughout the disease and abnormal respiratory function tests have been documented in 30%–40%,<a class="elsevierStyleCrossRefs" href="#bib0455"><span class="elsevierStyleSup">5–7</span></a> as well as anomalies on computed tomographic scans in 55%–70%.<a class="elsevierStyleCrossRef" href="#bib0465"><span class="elsevierStyleSup">7</span></a> In the Latin American GLADEL (Grupo Latino Americano de Estudio del Lupus) cohort, at least one pleuropulmonary manifestation was observed in 421 of the 1480 patients included (28.4%).<a class="elsevierStyleCrossRef" href="#bib0470"><span class="elsevierStyleSup">8</span></a></p><p id="par0010" class="elsevierStylePara elsevierViewall">Lung anomalies do not correlate with serum markers of lupus activity. It is essential to rule out pulmonary infection in the initial evaluation, as bacterial infection (67%) has been reported to be the most frequent parenchymatous involvement<a class="elsevierStyleCrossRef" href="#bib0435"><span class="elsevierStyleSup">1</span></a> and is one of the major causes of death.<a class="elsevierStyleCrossRef" href="#bib0475"><span class="elsevierStyleSup">9</span></a> In 2007, Kinder et al.<a class="elsevierStyleCrossRef" href="#bib0480"><span class="elsevierStyleSup">10</span></a> reviewed cases of pneumonia in a cohort of SLE patients and identified the etiology to be bacterial in 75%, mycobacterial in 12%, mycotic in 7% and viral in 5%. The participation of atypical agents and/or opportunist pathogens has also been described.<a class="elsevierStyleCrossRef" href="#bib0485"><span class="elsevierStyleSup">11</span></a></p><p id="par0015" class="elsevierStylePara elsevierViewall">The risk factors reported for pleuropulmonary involvement in SLE include age at diagnosis of generalized lupus erythematosus (GLE) ≥30 years (odds ratio [OR] 1.42; 95% confidence interval [CI]: 1.10–1.83), presence of lower respiratory tract infections (OR 3.19; 95% CI: 2.05–4.96), nonischemic heart disease (OR 3.17; 95% CI: 2.41–4.18), ischemic heart disease (OR 3.39: 95% CI: 2.08–5.54), systemic (OR 2.00; 95% CI: 1.37–2.91), ophthalmic (OR 1.58; 95% CI: 1.16–2.14) and renal manifestations (OR 1.44; 95% CI: 1.09–1.83),<a class="elsevierStyleCrossRef" href="#bib0470"><span class="elsevierStyleSup">8</span></a> hypocomplementemia (relative risk [RR] 3.38; 95% CI: 2.17–5.24) and high titers of anti-double-stranded (ds) DNA antibodies (RR 1.30; 95% CI: 0.78–2.24).<a class="elsevierStyleCrossRef" href="#bib0490"><span class="elsevierStyleSup">12</span></a></p><p id="par0020" class="elsevierStylePara elsevierViewall">The conditions that constitute pleuropulmonary involvement in SLE are considered primary when they are directly attributed to SLE or secondary when they are attributable to other causes. Among the latter, infections have a prevalence of nearly 60% and have been responsible for from 30% to 50% of the deaths of patients with SLE.<a class="elsevierStyleCrossRef" href="#bib0475"><span class="elsevierStyleSup">9</span></a> Acute respiratory distress syndrome (ARDS) has a variable prevalence of 4%–15% with mortality of nearly 70% and it is mostly secondary to sepsis.</p><p id="par0025" class="elsevierStylePara elsevierViewall">Drugs like methotrexate (MTX) and rituximab can result in pneumonitis and even progression to interstitial lung disease. Likewise, a slight increase in the risk of neoplasms in general, pulmonary in particular, has been reported in SLE patients.<a class="elsevierStyleCrossRef" href="#bib0440"><span class="elsevierStyleSup">2</span></a></p><p id="par0030" class="elsevierStylePara elsevierViewall">The disorders that constitute pleuropulmonary involvement in SLE are grouped according to the structures affected:<ul class="elsevierStyleList" id="lis0005"><li class="elsevierStyleListItem" id="lsti0005"><span class="elsevierStyleLabel">•</span><p id="par0035" class="elsevierStylePara elsevierViewall">Parenchymal involvement<a class="elsevierStyleCrossRef" href="#bib0440"><span class="elsevierStyleSup">2</span></a>:<ul class="elsevierStyleList" id="lis0010"><li class="elsevierStyleListItem" id="lsti0010"><span class="elsevierStyleLabel">∘</span><p id="par0040" class="elsevierStylePara elsevierViewall">Lupus pneumonitis: prevalence from 1% to 12%.</p></li><li class="elsevierStyleListItem" id="lsti0015"><span class="elsevierStyleLabel">∘</span><p id="par0045" class="elsevierStylePara elsevierViewall">Chronic interstitial lung disease: prevalence from 3% to 13%.</p></li><li class="elsevierStyleListItem" id="lsti0020"><span class="elsevierStyleLabel">∘</span><p id="par0050" class="elsevierStylePara elsevierViewall">Diffuse alveolar hemorrhage (DAH): prevalence from 2% to 6%, high mortality.</p></li></ul></p></li><li class="elsevierStyleListItem" id="lsti0025"><span class="elsevierStyleLabel">•</span><p id="par0055" class="elsevierStylePara elsevierViewall">Pleural involvement: 50%–70%, in the form of pleuritis and/or effusion.<a class="elsevierStyleCrossRef" href="#bib0440"><span class="elsevierStyleSup">2</span></a></p></li><li class="elsevierStyleListItem" id="lsti0030"><span class="elsevierStyleLabel">•</span><p id="par0060" class="elsevierStylePara elsevierViewall">Vascular involvement:<ul class="elsevierStyleList" id="lis0015"><li class="elsevierStyleListItem" id="lsti0035"><span class="elsevierStyleLabel">∘</span><p id="par0065" class="elsevierStylePara elsevierViewall">Pulmonary hypertension: prevalence of 0.5%–4.2%.<a class="elsevierStyleCrossRef" href="#bib0495"><span class="elsevierStyleSup">13</span></a></p></li><li class="elsevierStyleListItem" id="lsti0040"><span class="elsevierStyleLabel">∘</span><p id="par0070" class="elsevierStylePara elsevierViewall">Embolism/pulmonary thromboembolism (PTE): deep venous thrombosis with/without PTE in 9%, related to activity. The presence of antiphospholipid antibodies (in up to 30% of the patients with SLE) increases the risk of thromboembolic events by 35%–40%.<a class="elsevierStyleCrossRef" href="#bib0500"><span class="elsevierStyleSup">14</span></a></p></li><li class="elsevierStyleListItem" id="lsti0045"><span class="elsevierStyleLabel">∘</span><p id="par0075" class="elsevierStylePara elsevierViewall">Acute reversible hypoxemia: a rare condition that is characterized by unexplained hypoxemia with no evidence of parenchymal involvement. Its pathophysiology is controversial, but leukocyte aggregation and complement activation in the pulmonary vasculature have been proposed. It has a good response to steroids within 72<span class="elsevierStyleHsp" style=""></span>h.<a class="elsevierStyleCrossRef" href="#bib0445"><span class="elsevierStyleSup">3</span></a></p></li></ul></p></li><li class="elsevierStyleListItem" id="lsti0050"><span class="elsevierStyleLabel">•</span><p id="par0080" class="elsevierStylePara elsevierViewall">Shrinking lung syndrome: prevalence of 0.6%–0.9%, characterized by unexplained dyspnea, elevated diaphragm and reduced lung volumes without interstitial involvement. The etiology is controversial but phrenic neuropathy, inflammatory myopathy and, more recently, pleural disease have been suggested. It responds well to steroids.<a class="elsevierStyleCrossRef" href="#bib0500"><span class="elsevierStyleSup">14</span></a></p></li><li class="elsevierStyleListItem" id="lsti0055"><span class="elsevierStyleLabel">•</span><p id="par0085" class="elsevierStylePara elsevierViewall">Airways: both lower and upper, with a prevalence that ranges from 0.3% to 30%; its course is predominantly subclinical.<a class="elsevierStyleCrossRef" href="#bib0445"><span class="elsevierStyleSup">3</span></a></p></li></ul></p><p id="par0090" class="elsevierStylePara elsevierViewall">Below we review the epidemiological, clinical, diagnostic and treatment aspects concerning the conditions that the authors considered to be of particular interest due to their high frequency or because of the severity they represent.</p><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0025">Pleural Involvement</span><p id="par0095" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleItalic">Prevalence.</span> Pleuritis constitutes the most widespread thoracic manifestation in SLE. Pleuritic pain is present in 45%–60% of the patients, pleural effusion in up to 50% and, in autopsies, it has been reported to be encountered in up to 93%.<a class="elsevierStyleCrossRef" href="#bib0440"><span class="elsevierStyleSup">2</span></a> The experience documented in the GLADEL cohort is similar; pleural involvement was the most common pleuropulmonary manifestation (24%),<a class="elsevierStyleCrossRef" href="#bib0470"><span class="elsevierStyleSup">8</span></a> and it was observed that ischemic and nonischemic heart disease (OR 2.99; 95% CI: 2.33–3.82 and OR 1.99; 95% CI: 1.28–2.09, respectively) constitute risk factors. Other factors include the presence lupus nephritis, hypocomplementemia (C3 and C4) and high levels of anti-dsDNA antibodies.<a class="elsevierStyleCrossRef" href="#bib0490"><span class="elsevierStyleSup">12</span></a> A recent study that included 119 patients with SLE and pleural involvement demonstrated that, even in regions in which tuberculosis is endemic, the main etiology of pleural effusion in these patients continues to be the underlying disease (52%).<a class="elsevierStyleCrossRef" href="#bib0505"><span class="elsevierStyleSup">15</span></a></p><p id="par0100" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleItalic">Clinical aspects.</span> The main symptom is pleuritic pain, usually accompanied by fever, cough and dyspnea. On occasion, pleural effusion is asymptomatic and can only be detected by radiography. The effusions are usually small and bilateral, although they can also be unilateral. They tend to be evanescent and recurrent.<a class="elsevierStyleCrossRef" href="#bib0510"><span class="elsevierStyleSup">16</span></a></p><p id="par0105" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleItalic">Diagnostic aspects.</span> The differential diagnosis should include musculoskeletal pain, pulmonary embolism, infection, heart failure, uremia and neoplasm. Analysis of the pleural fluid is the main diagnostic tool. This typically is an exudate with a slight elevation of leukocytes, predomination of mononuclear cells (there are also polymorphonuclear cells) and normal or slightly low glucose levels. The differential diagnosis should include rheumatoid arthritis (RA), characterized by a higher level of leukocytes and lactate dehydrogenase, as well as a low glucose level.<a class="elsevierStyleCrossRef" href="#bib0440"><span class="elsevierStyleSup">2</span></a> The role of the detection of antinuclear antibodies (ANA) in pleural fluid for the diagnosis of lupus pleuritis is controversial. Two recent studies<a class="elsevierStyleCrossRefs" href="#bib0515"><span class="elsevierStyleSup">17,18</span></a> have reported ANA at titers >1:160 with sensitivity of 85%–90% and specificity of 80% for the diagnosis of lupus pleuritis in patients with lupus; however, high titers can also be encountered in other conditions. <a class="elsevierStyleCrossRef" href="#fig0005">Fig. 1</a> shows evidence of pleural effusion in a patient with lupus who reported clinical data associated with pleural involvement.</p><elsevierMultimedia ident="fig0005"></elsevierMultimedia><p id="par0110" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleItalic">Pleural biopsy</span>. Rarely performed, usually only when the diagnosis is uncertain. The findings are nonspecific: lymphocytic and plasma cell infiltration, fibrosis and fibrinous pleuritis. Immunofluorescence shows a nuclear pattern with anti-IgG, anti-IgM and anti-C3.<a class="elsevierStyleCrossRef" href="#bib0510"><span class="elsevierStyleSup">16</span></a></p><p id="par0115" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleItalic">Complications.</span> Usually benign course, although a case was reported in which the patient developed fibrothorax with severe restriction; the response to pleurectomy was favorable.<a class="elsevierStyleCrossRef" href="#bib0525"><span class="elsevierStyleSup">19</span></a></p><p id="par0120" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleItalic">Treatment.</span> Most patients respond to nonsteroidal anti-inflammatory drugs (NSAID) or oral steroids (prednisone at 10–30<span class="elsevierStyleHsp" style=""></span>mg/day). Azathioprine has been employed as a steroid-sparing agent and cyclophosphamide only when there is concomitant systemic involvement. Pleurodesis with tetracycline or talc has been employed in large recurrent effusions.<a class="elsevierStyleCrossRef" href="#bib0440"><span class="elsevierStyleSup">2</span></a></p></span><span id="sec0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0030">Acute Pneumonitis</span><p id="par0125" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleItalic">Prevalence.</span> A number of series describe a variable prevalence of between 2% and 9%.<a class="elsevierStyleCrossRefs" href="#bib0530"><span class="elsevierStyleSup">20–25</span></a> Five corroborated cases have been reported over the past 8 years. In the GLADEL cohort, it was reported in 2.3% of the patients and was associated with nonischemic heart disease (OR 2.48; 95% CI: 1.20–5.13).<a class="elsevierStyleCrossRef" href="#bib0470"><span class="elsevierStyleSup">8</span></a></p><p id="par0130" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleItalic">Clinical aspects.</span> Acute and nonspecific onset: cough with or without hemoptysis, dyspnea and fever. In severe cases, there can be hypoxemia and even acute respiratory failure. It can be the initial manifestation of SLE in up to half of the patients who develop it.<a class="elsevierStyleCrossRef" href="#bib0560"><span class="elsevierStyleSup">26</span></a> The characteristic radiographic image consists of uni/bilateral alveolar infiltrates, usually with predominance at the lung base.<a class="elsevierStyleCrossRef" href="#bib0565"><span class="elsevierStyleSup">27</span></a> Wan et al. recently reported a series of 5 cases in which lupus pneumonitis constituted the initial manifestation; 100% had pulmonary images on radiographs, chest computed tomography (performed in 2 patients) showed ground glass opacities and bilateral patchy consolidation. All had additional manifestation of GLE that enabled the diagnosis: mucocutaneous in 100%, hematological in 80%, serositis in 40% and 60% were positive for anti-dsDNA antobodies.<a class="elsevierStyleCrossRef" href="#bib0570"><span class="elsevierStyleSup">28</span></a></p><p id="par0135" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleItalic">Initial management and diagnosis.</span> The main condition to be included in the differential diagnosis is infection; it is necessary to initiate empirical antibody coverage after the collection of cultures to deescalate or discontinue it if infection is ruled out.<a class="elsevierStyleCrossRef" href="#bib0565"><span class="elsevierStyleSup">27</span></a></p><p id="par0140" class="elsevierStylePara elsevierViewall">Association with high titers of anti-dsDNA antibodies has been described. The utility of bronchoalveolar lavage (BAL) lies in that it rules out infection; characteristically, there is an increase in cellularity at the expense of activated polymorphonuclear cells.<a class="elsevierStyleCrossRef" href="#bib0445"><span class="elsevierStyleSup">3</span></a> The extraction of a biopsy specimen can be limited to cases of uncertain diagnosis for the exclusion of alternative etiologies. The findings are nonspecific: damage to the alveolar wall and necrosis, infiltration by inflammatory cells, edema, hemorrhage and hyaline membranes.<a class="elsevierStyleCrossRef" href="#bib0510"><span class="elsevierStyleSup">16</span></a> A number of experts question the existence of this syndrome unless one or more of the following findings are demonstrated: interstitial fibrosis, vasculitis, hematoxylin bodies, interstitial pneumonitis, alveolitis or pleuritis.<a class="elsevierStyleCrossRef" href="#bib0565"><span class="elsevierStyleSup">27</span></a> It is useful to remember that, in terms of the diagnosis, the establishment of lupus pneumonitis is nearly always simultaneous with a flare of the disease, in general with multiple organ involvement (e.g., renal involvement and serositis) and, in most cases, this occurs in the presence of anti-SSA antibodies (82%). Thus, the combination of pneumonitis with multiorgan involvement in a patient who is positive for anti-SSA supports the diagnosis.<a class="elsevierStyleCrossRef" href="#bib0575"><span class="elsevierStyleSup">29</span></a><a class="elsevierStyleCrossRef" href="#fig0010">Fig. 2</a> shows an example of a computed tomography from a patient with lupus pneumonitis.</p><elsevierMultimedia ident="fig0010"></elsevierMultimedia><p id="par0145" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleItalic">Prognosis.</span> Historic series report a mortality of up to 50%; the most recent series reported a mortality rate of 40%.<a class="elsevierStyleCrossRef" href="#bib0570"><span class="elsevierStyleSup">28</span></a> Although it is an uncommon complication, lupus pneumonitis during pregnancy and the postpartum has been associated with especially adverse outcomes.<a class="elsevierStyleCrossRefs" href="#bib0575"><span class="elsevierStyleSup">29–31</span></a> The predominance of lymphocytes in BAL is associated with a more favorable course, whereas the predominance of eosinophils or neutrophils is associated with a higher rate of mortality. In up to 50% of the survivors, interstitial infiltrates and abnormal respiratory function persist, with risk of progression to chronic interstitial pneumonitis.<a class="elsevierStyleCrossRefs" href="#bib0445"><span class="elsevierStyleSup">3,14</span></a><a class="elsevierStyleCrossRef" href="#fig0015">Fig. 3</a> shows the findings in pneumonitis and pulmonary hypertension.</p><elsevierMultimedia ident="fig0015"></elsevierMultimedia><p id="par0150" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleItalic">Treatment.</span> There are no controlled studies; the current approach is based on case reports. Broad-spectrum antibiotic coverage is indispensable until infection is ruled out. The cornerstone of treatment is prednisone at a dose of 1 to 1.5<span class="elsevierStyleHsp" style=""></span>mg/kg body weight (bw)/day.<a class="elsevierStyleCrossRef" href="#bib0565"><span class="elsevierStyleSup">27</span></a> If there is no response in 72<span class="elsevierStyleHsp" style=""></span>h, the recommendation is the administration of intravenous pulses of glucocorticoids (methylprednisolone at 1<span class="elsevierStyleHsp" style=""></span>g/day for 3 days); it is necessary to consider adding an immunosuppressive agent like cyclophosphamide. Patients with significant tachypnea or hypoxemia and/or those in whom alveolar hemorrhage is suspected should be admitted to the intensive care unit, and it is essential to employ methylprednisolone pulses as the initial treatment.<a class="elsevierStyleCrossRef" href="#bib0440"><span class="elsevierStyleSup">2</span></a> There are reports of cases of different degrees of success with azathioprine, intravenous gammaglobulin, plasmapheresis and rituximab.<a class="elsevierStyleCrossRefs" href="#bib0440"><span class="elsevierStyleSup">2,32,33</span></a> In the retrospective review by Wan et al., all the patients received high doses of a glucocorticoid, 80% intravenous cyclophosphamide and 60% intravenous immunoglobulin.<a class="elsevierStyleCrossRef" href="#bib0570"><span class="elsevierStyleSup">28</span></a></p><p id="par0155" class="elsevierStylePara elsevierViewall">It has been observed that influenza infections can activate and exacerbate GLE in general and lupus pneumonitis, as well. Although the humoral response to an influence vaccine is weaker than in the general population, vaccination in patients with GLE with low-to-moderate activity is moderately effective and safe. The available information does not warrant our making recommendations in reference to GLE with high activity.<a class="elsevierStyleCrossRef" href="#bib0600"><span class="elsevierStyleSup">34</span></a></p></span><span id="sec0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0035">Chronic Interstitial Lung Disease</span><p id="par0160" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleItalic">Prevalence.</span> Reported in from 3% to 8% of the population, it has been observed that it increases with disease duration.<a class="elsevierStyleCrossRef" href="#bib0605"><span class="elsevierStyleSup">35</span></a> Several cohorts of SLE patients have found a reduction in carbon monoxide diffusion capacity in 27%–56%, a restrictive pattern in 8%–80%<a class="elsevierStyleCrossRefs" href="#bib0460"><span class="elsevierStyleSup">6,7,36</span></a> and interstitial involvement in high-resolution computed tomography (HRCT) in 30%–40% of those included; however, the majority are asymptomatic (50%–90%).<a class="elsevierStyleCrossRefs" href="#bib0455"><span class="elsevierStyleSup">5,7,36,37</span></a> This suggests that there is a subclinical course in most of those affected. The known risk factors include disease duration of >10 years, Raynaud's phenomenon, anti-U1 ribonucleoprotein antibodies, sclerodactyly, capillaroscopic changes and older age.<a class="elsevierStyleCrossRef" href="#bib0620"><span class="elsevierStyleSup">38</span></a></p><p id="par0165" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleItalic">Clinical aspects.</span> It usually predominates in men over 50 years of age with late-onset or long-standing (>10 years) SLE.<a class="elsevierStyleCrossRef" href="#bib0560"><span class="elsevierStyleSup">26</span></a> The course is usually insidious, but it can develop after one or more episodes of acute pneumonitis. It generally consists of dyspnea on exertion, occasional pleuritic pain, dry cough and bibasal rales.<a class="elsevierStyleCrossRef" href="#bib0440"><span class="elsevierStyleSup">2</span></a> In the early stages, radiographic images may be normal or show irregular linear opacities. Later studies show diffuse or bibasal infiltrates, pleural disease, honeycombing and reduced lung volumes. High-resolution computed tomography defines the presence and the pattern of the disease.<a class="elsevierStyleCrossRef" href="#bib0625"><span class="elsevierStyleSup">39</span></a> The severity of the lung involvement does not correlate with the serological markers.<a class="elsevierStyleCrossRef" href="#bib0510"><span class="elsevierStyleSup">16</span></a> However, the association of anti-Ro/SSA has been reported in up to 80% of the patients.<a class="elsevierStyleCrossRef" href="#bib0630"><span class="elsevierStyleSup">40</span></a> This suggests a possible contribution of secondary Sjögren's syndrome. Lymphoid interstitial pneumonia (LIP) is associated with Sjögren's syndrome in up to 53%; there are reports of LIP in SLE without and with secondary Sjögren's syndrome.<a class="elsevierStyleCrossRefs" href="#bib0635"><span class="elsevierStyleSup">41,42</span></a></p><p id="par0170" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleItalic">Diagnosis.</span> The following are included among the available diagnostic tools:<ul class="elsevierStyleList" id="lis0020"><li class="elsevierStyleListItem" id="lsti0060"><span class="elsevierStyleLabel">•</span><p id="par0175" class="elsevierStylePara elsevierViewall">High-resolution computed tomography: corroborates the presence of interstitial disease and makes it possible to classify it in accordance with the patterns observed, which are highly similar to those encountered in systemic sclerosis<a class="elsevierStyleCrossRefs" href="#bib0605"><span class="elsevierStyleSup">35,39</span></a>:</p></li><li class="elsevierStyleListItem" id="lsti0065"><span class="elsevierStyleLabel">∘</span><p id="par0180" class="elsevierStylePara elsevierViewall">Nonspecific interstitial pneumonia (NSIP): patches of ground glass and reticular pattern.</p></li><li class="elsevierStyleListItem" id="lsti0070"><span class="elsevierStyleLabel">∘</span><p id="par0185" class="elsevierStylePara elsevierViewall">Usual interstitial pneumonia (UIP): reticular opacities with predominantly subpleural and basal honeycombing, with or without traction bronchiectasis.</p></li><li class="elsevierStyleListItem" id="lsti0075"><span class="elsevierStyleLabel">∘</span><p id="par0190" class="elsevierStylePara elsevierViewall">Lymphoid interstitial pneumonia (LIP): less common. Diffuse ground glass opacities, reticular pattern and perivascular cysts.</p></li><li class="elsevierStyleListItem" id="lsti0080"><span class="elsevierStyleLabel">•</span><p id="par0195" class="elsevierStylePara elsevierViewall">Respiratory function tests: document the extension and progression. Restrictive pattern, reduced carbon monoxide diffusion capacity and exercise-induced desaturation are characteristic.<a class="elsevierStyleCrossRefs" href="#bib0560"><span class="elsevierStyleSup">26,35</span></a></p></li><li class="elsevierStyleListItem" id="lsti0085"><span class="elsevierStyleLabel">•</span><p id="par0200" class="elsevierStylePara elsevierViewall">Bronchoalveolar lavage: its main utility lies in that it excludes other etiologies. The relationship to the prognosis is not well-established. The analysis of the BAL fluid in asymptomatic patients suggests subclinical alveolitis.26 A study conducted by Chhajed et al. in patients with SLE and RA demonstrated a predominance of macrophages, followed by lymphocytes and neutrophils, as well as a relationship between lymphocytic predominance in individuals with pulmonary symptoms and predominance of neutrophils and lymphocytes in those with radiological evidence of interstitial lung disease.<a class="elsevierStyleCrossRef" href="#bib0645"><span class="elsevierStyleSup">43</span></a></p></li><li class="elsevierStyleListItem" id="lsti0090"><span class="elsevierStyleLabel">•</span><p id="par0205" class="elsevierStylePara elsevierViewall">Biopsy: recommended if the diagnosis is uncertain despite noninvasive studies.<a class="elsevierStyleCrossRefs" href="#bib0560"><span class="elsevierStyleSup">26,35</span></a></p></li><li class="elsevierStyleListItem" id="lsti0095"><span class="elsevierStyleLabel">∘</span><p id="par0210" class="elsevierStylePara elsevierViewall">NSIP: the most common type. We stress the chronic lymphocytic infiltrate (lymphocytes/plasma cells), absence of fibrosis.</p></li><li class="elsevierStyleListItem" id="lsti0100"><span class="elsevierStyleLabel">∘</span><p id="par0215" class="elsevierStylePara elsevierViewall">UIP: patches of fibrosis with remodeling of lung architecture, moderate chronic interstitial inflammation.</p></li><li class="elsevierStyleListItem" id="lsti0105"><span class="elsevierStyleLabel">∘</span><p id="par0220" class="elsevierStylePara elsevierViewall">LIP: diffuse interstitial inflammatory infiltrate marked by lymphocytes, plasma cells and histiocytes.</p></li><li class="elsevierStyleListItem" id="lsti0110"><span class="elsevierStyleLabel">∘</span><p id="par0225" class="elsevierStylePara elsevierViewall">Less common associations with amyloidosis and cryptogenic organizing pneumonia have also been reported.</p></li></ul></p><p id="par0230" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleItalic">Treatment.</span> There are no controlled clinical trials. There are small studies that initially showed a favorable response and an increase in the carbon monoxide diffusion capacity with prednisone at a dose of 60<span class="elsevierStyleHsp" style=""></span>mg/kg bw. The rest of the therapeutic approaches have been extrapolated from those utilized in systemic sclerosis due to the similarity of the interstitial involvement.<a class="elsevierStyleCrossRefs" href="#bib0445"><span class="elsevierStyleSup">3,44</span></a> In cases in which the severity is low-to-moderate, prednisone has been employed as monotherapy, but it has more frequently been associated with another immunosuppressive agent. In severe or progressive disease, the treatment is prednisone at 1–2<span class="elsevierStyleHsp" style=""></span>mg/kg bw and cyclophosphamide, with a subsequent change to azathioprine or mycophenolate mofetil.<a class="elsevierStyleCrossRef" href="#bib0500"><span class="elsevierStyleSup">14</span></a> The real-world experience with cyclophosphamide is limited; there are case reports involving MTX and, recently, with rituximab, both with favorable responses.<a class="elsevierStyleCrossRefs" href="#bib0655"><span class="elsevierStyleSup">45–48</span></a><span class="elsevierStyleItalic">Prognosis</span>. The disease course is variable but the changes occur slowly; it is rarely progressive and the trend is toward stabilization over time.<a class="elsevierStyleCrossRef" href="#bib0560"><span class="elsevierStyleSup">26</span></a> A historical series reported insignificant changes in the main parameters of respiratory function tests.<a class="elsevierStyleCrossRef" href="#bib0675"><span class="elsevierStyleSup">49</span></a> Patients with evidence of scleroderma or with overlap syndromes usually have a higher prevalence of restriction.<a class="elsevierStyleCrossRef" href="#bib0560"><span class="elsevierStyleSup">26</span></a> In accordance with the histological pattern, in a series of biopsies including patients with RA, Sjögren's syndrome, polymyositis and SLE, the most common pattern was NSIP (41%), with a mortality rate of 24%; the most frequently associated pattern was the fibrotic form.<a class="elsevierStyleCrossRef" href="#bib0680"><span class="elsevierStyleSup">50</span></a></p></span><span id="sec0020" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0040">Diffuse Alveolar Hemorrhage (DAH)</span><p id="par0235" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleItalic">Prevalence.</span> It is variable, from 0.6% to 5.7%; however, survival continues to be unacceptably low in most reports.<a class="elsevierStyleCrossRefs" href="#bib0685"><span class="elsevierStyleSup">51–57</span></a> In 2011, researchers from our group documented a prevalence and survival of 9% and 49.7%, respectively.<a class="elsevierStyleCrossRef" href="#bib0720"><span class="elsevierStyleSup">58</span></a></p><p id="par0240" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleItalic">Pathophysiology.</span> It has not been completely clarified. Evidence suggests that the disease activity plays a crucial role since most of the series report high Systemic Lupus Erythematosus Disease Activity Index (SLEDAI) scores (>12), concomitant high prevalence of nephritis (66%–100%), arthritis (15%–75%) and neuropsychiatric manifestations (20%–60%), as well as polymorphonuclear leukocyte infiltration and, occasionally, immune complex deposition in capillaries (capillaritis) and alveolar wall, although the majority of the patients had “bland” hemorrhage (blood in alveoli without inflammation or destruction of the wall).<a class="elsevierStyleCrossRef" href="#bib0730"><span class="elsevierStyleSup">60</span></a> This, in accordance with the series of autopsies of SLE patients reported in 1981 and 2009, suggests that processes like aspiration, infection, heart failure and renal failure may largely contribute to the pathogenesis of DAH.<a class="elsevierStyleCrossRefs" href="#bib0435"><span class="elsevierStyleSup">1,61</span></a> At the present time, we recognize 3 histopathological patterns that can frequently overlap: pulmonary capillaritis (neutrophilic infiltration of alveolar septa, loss of capillary structural integrity and passage of erythrocytes into alveolar spaces and interstitium; in some cases, the participation of antiphospholipid antibodies has been implicated in this process), bland pulmonary hemorrhage (accumulation of erythrocytes and fibrin in alveolar spaces without inflammation or destruction of alveolar structures) and diffuse alveolar damage (edema of alveolar septa and formation of hyaline membranes).<a class="elsevierStyleCrossRef" href="#bib0740"><span class="elsevierStyleSup">62</span></a></p><p id="par0245" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleItalic">Risk factors.</span> They have been poorly described, but a strong association has been established with disease activity; particularly with class III and class IV lupus nephritis (90%),<a class="elsevierStyleCrossRefs" href="#bib0730"><span class="elsevierStyleSup">60,63</span></a> high titers of anti-dsDNA antibodies, low complement levels, SLEDAI score >10<a class="elsevierStyleCrossRef" href="#bib0715"><span class="elsevierStyleSup">57</span></a> and neuropsychiatric manifestations.<a class="elsevierStyleCrossRef" href="#bib0710"><span class="elsevierStyleSup">56</span></a></p><p id="par0250" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleItalic">Clinical aspects.</span> The majority of the cases described occur in women, the duration of SLE prior to DAH is variable (6 months–14 years) and it can be the initial event in 10%–30%.<a class="elsevierStyleCrossRefs" href="#bib0700"><span class="elsevierStyleSup">54,64</span></a> It consists of dyspnea, decreasing hemoglobin, changing radiographic infiltrates and hemoptysis may be present (it is absent in up to 30%–50% of the patients).<a class="elsevierStyleCrossRef" href="#bib0755"><span class="elsevierStyleSup">65</span></a> The radiographic features that suggest the presence of DAH include the sudden development of infiltrates, poor response to antibiotics and the rapid radiographic resolution after management with corticosteroids.<a class="elsevierStyleCrossRef" href="#bib0700"><span class="elsevierStyleSup">54</span></a> Bilateral diffuse alveolar infiltrates have been found in most patients; on occasion, alveolo-interstitial infiltrates are observed, that may be unilateral in 20% or patchy in 40%. High-resolution computed tomography is the most sensitive technique for the proper assessment of the pattern and distribution of DAH, as well as the associated pulmonary changes.<a class="elsevierStyleCrossRefs" href="#bib0630"><span class="elsevierStyleSup">40,65</span></a></p><p id="par0255" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleItalic">Diagnosis.</span> It can be corroborated by the clinical findings, the unexplained decrease in hemoglobin, the characteristic radiographic findings and the favorable response to treatment. <a class="elsevierStyleCrossRef" href="#fig0020">Fig. 4</a> is a radiograph showing alveolar images characteristic of alveolar hemorrhage. Certain tools that may contribute to the diagnosis include:<ul class="elsevierStyleList" id="lis0025"><li class="elsevierStyleListItem" id="lsti0115"><span class="elsevierStyleLabel">•</span><p id="par0260" class="elsevierStylePara elsevierViewall">Carbon monoxide diffusion capacity: some series report an increase of 30% over the baseline or a rise of >130% over the predicted value. Difficult to perform or not viable in most patients because of their critical condition.<a class="elsevierStyleCrossRef" href="#bib0685"><span class="elsevierStyleSup">51</span></a></p></li><li class="elsevierStyleListItem" id="lsti0120"><span class="elsevierStyleLabel">•</span><p id="par0265" class="elsevierStylePara elsevierViewall">BAL: confirms or rules out infection and the presence of hemosiderophages. Useful in patients with nonspecific manifestations.<a class="elsevierStyleCrossRefs" href="#bib0700"><span class="elsevierStyleSup">54,59</span></a></p></li><li class="elsevierStyleListItem" id="lsti0125"><span class="elsevierStyleLabel">•</span><p id="par0270" class="elsevierStylePara elsevierViewall">Biopsy: rarely performed due to the morbidity and mortality rates in critical patients. Capillaritis and depositions of immune complexes and neutrophils in alveolar walls have been described in 14%. The predominant finding is bland hemorrhage (72%).<a class="elsevierStyleCrossRefs" href="#bib0760"><span class="elsevierStyleSup">66,67</span></a></p></li></ul></p><elsevierMultimedia ident="fig0020"></elsevierMultimedia><p id="par0275" class="elsevierStylePara elsevierViewall">The differential diagnosis should consider: pulmonary embolism, heart failure, lupus pneumonitis and infection, the latter two are among the principal conditions.<a class="elsevierStyleCrossRef" href="#bib0440"><span class="elsevierStyleSup">2</span></a></p><p id="par0280" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleItalic">Infection.</span> Recent studies have shown that concomitant pulmonary infection is present in up to 60% of the patients with DAH<a class="elsevierStyleCrossRef" href="#bib0695"><span class="elsevierStyleSup">53</span></a>; likewise this factor is associated with a higher rate of mortality. The microorganisms commonly reported include <span class="elsevierStyleItalic">Pseudomonas</span> spp, <span class="elsevierStyleItalic">Aspergillus, Staphylococcus aureus</span> and cytomegalovirus.<a class="elsevierStyleCrossRef" href="#bib0725"><span class="elsevierStyleSup">59</span></a> In the cohort studied by our group,<a class="elsevierStyleCrossRef" href="#bib0770"><span class="elsevierStyleSup">68</span></a> which included 50 patients, we reported a mortality of 42% and infection in 38%. The factors associated with a higher risk of infection were: mechanical ventilation, hypocomplementemia and high C-reactive protein levels. In contrast, in patients who had had no previous treatment for SLE, we observed a lower frequency of infectious processes.</p><p id="par0285" class="elsevierStylePara elsevierViewall">In a previous article by our group, we stressed the importance of a systematic search for infection in all patients with DAH, given the possibility of opportunists and even the need for thoracoscopy to collect a biopsy specimen, taking into account the risk-benefit in each case. Likewise, it is necessary to institute empirical broad-spectrum antibiotic coverage as part of the initial management.<a class="elsevierStyleCrossRefs" href="#bib0700"><span class="elsevierStyleSup">54,56</span></a></p><p id="par0290" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleItalic">Prognosis and mortality factors.</span> Episodes of DAH can recur and survivors may continue to have persistently abnormal respiratory function tests. The mortality reported 30 years ago was as high as 90%; over the past 15 years it ranges between 40% and 60%.<a class="elsevierStyleCrossRef" href="#bib0725"><span class="elsevierStyleSup">59</span></a> Among the factors associated with a higher rate of mortality, we stress the presence of concomitant pulmonary infection, renal failure, the need for mechanical ventilation, thrombocytopenia and a high Acute Physiology and Chronic Health Evaluation (APACHE II) score; the last 4 factors are those most frequently associated.<a class="elsevierStyleCrossRefs" href="#bib0685"><span class="elsevierStyleSup">51,54–56,69</span></a></p><p id="par0295" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleItalic">Treatment.</span> As in the other conditions described above, there are no controlled clinical trials and the current approach to treatment derives from case reports and case series. The following include those that are most widely employed<a class="elsevierStyleCrossRef" href="#bib0725"><span class="elsevierStyleSup">59</span></a>:<ul class="elsevierStyleList" id="lis0030"><li class="elsevierStyleListItem" id="lsti0130"><span class="elsevierStyleLabel">•</span><p id="par0300" class="elsevierStylePara elsevierViewall">Intravenous pulses of methylprednisolone of 1<span class="elsevierStyleHsp" style=""></span>g/day for 3 or more days until clinical improvement is observed, which is associated with a longer survival.<a class="elsevierStyleCrossRef" href="#bib0780"><span class="elsevierStyleSup">70</span></a></p></li><li class="elsevierStyleListItem" id="lsti0135"><span class="elsevierStyleLabel">•</span><p id="par0305" class="elsevierStylePara elsevierViewall">Cyclophosphamide: initially associated with a higher rate of mortality (employed in patients who were more severely ill); however recent series have demonstrated no effect or that it served to protect against mortality.<a class="elsevierStyleCrossRefs" href="#bib0700"><span class="elsevierStyleSup">54,55,63</span></a></p></li><li class="elsevierStyleListItem" id="lsti0140"><span class="elsevierStyleLabel">•</span><p id="par0310" class="elsevierStylePara elsevierViewall">Plasmapheresis: usually together with pulses of methylprednisolone and cyclophosphamide in cases of poor response; its utility alone has not been specified, but a reduction in the mortality of 20% has been documented.<a class="elsevierStyleCrossRef" href="#bib0725"><span class="elsevierStyleSup">59</span></a></p></li><li class="elsevierStyleListItem" id="lsti0145"><span class="elsevierStyleLabel">•</span><p id="par0315" class="elsevierStylePara elsevierViewall">Immunoglobulin: employed in a case series, with no impact on mortality.<a class="elsevierStyleCrossRef" href="#bib0700"><span class="elsevierStyleSup">54</span></a></p></li><li class="elsevierStyleListItem" id="lsti0150"><span class="elsevierStyleLabel">•</span><p id="par0320" class="elsevierStylePara elsevierViewall">Rituximab: employing immunoregulatory mechanisms other than B-cell depletion,<a class="elsevierStyleCrossRef" href="#bib0785"><span class="elsevierStyleSup">71</span></a> it has a favorable and relatively rapid response that is observed in case series and isolated case reports, particularly with a reduction in recurrence.<a class="elsevierStyleCrossRefs" href="#bib0790"><span class="elsevierStyleSup">72–78</span></a></p></li><li class="elsevierStyleListItem" id="lsti0155"><span class="elsevierStyleLabel">•</span><p id="par0325" class="elsevierStylePara elsevierViewall">There are small series and case reports with variable degrees of success with therapies that include transplantation of umbilical cord-derived mesenchymal cells, extracorporeal membrane oxygenation, factor VIIa and mycophenolate mofetil.<a class="elsevierStyleCrossRefs" href="#bib0825"><span class="elsevierStyleSup">79–86</span></a></p></li></ul></p></span><span id="sec0025" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0045">Conclusions and Outlooks</span><p id="par0330" class="elsevierStylePara elsevierViewall">Pulmonary involvement in SLE is highly prevalent (although a significant proportion of the patients may be asymptomatic). It can affect virtually any component of the respiratory system and may constitute the initial manifestation of SLE. In contrast to what we observe in other organs (skin, kidney, nervous system), pleuropulmonary involvement has a poor relationship or none at all with serological markers. The manifestations are similar, being nonspecific and their severity is variable.</p><p id="par0335" class="elsevierStylePara elsevierViewall">The differential diagnosis is extensive and the main suspect is an infectious process, which constitutes the main cause of death in SLE. Thus, it is essential to institute broad-spectrum antibiotic coverage in the initial approach.</p><p id="par0340" class="elsevierStylePara elsevierViewall">The current lack of controlled clinical trials limits the available therapeutic armamentarium for potentially fatal conditions such as acute pneumonitis and/or DAH; it is not likely that there be future studies of this nature due to the relative rarity of these disorders and their severity. The available therapeutic agents are, on occasion, quite unsatisfactory and their utilization in the severe pulmonary manifestations associated with SLE is derived mainly from case series and from experience obtained in other rheumatic diseases (like interstitial involvement in systemic sclerosis).</p><p id="par0345" class="elsevierStylePara elsevierViewall">The role that biological agents could have in these severe manifestation still continues to be under evaluation; we hope to obtain more information in this respect that derives from the use of these agents in case series.</p></span><span id="sec0030" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0050">Conflicts of Interest</span><p id="par0350" class="elsevierStylePara elsevierViewall">The authors declare they have no conflicts of interest concerning the present publication.</p><p id="par0355" class="elsevierStylePara elsevierViewall">Carlos Abud-Mendoza has been a lecturer for BMS, Pfizer, UCB and Roche and has occasionally participated in workshops as an advisor.</p></span></span>" "textoCompletoSecciones" => array:1 [ "secciones" => array:11 [ 0 => array:3 [ "identificador" => "xres1085086" "titulo" => "Abstract" "secciones" => array:1 [ 0 => array:1 [ "identificador" => "abst0005" ] ] ] 1 => array:2 [ "identificador" => "xpalclavsec1029557" "titulo" => "Keywords" ] 2 => array:3 [ "identificador" => "xres1085085" "titulo" => "Resumen" "secciones" => array:1 [ 0 => array:1 [ "identificador" => "abst0010" ] ] ] 3 => array:2 [ "identificador" => "xpalclavsec1029558" "titulo" => "Palabras clave" ] 4 => array:2 [ "identificador" => "sec0005" "titulo" => "Pleural Involvement" ] 5 => array:2 [ "identificador" => "sec0010" "titulo" => "Acute Pneumonitis" ] 6 => array:2 [ "identificador" => "sec0015" "titulo" => "Chronic Interstitial Lung Disease" ] 7 => array:2 [ "identificador" => "sec0020" "titulo" => "Diffuse Alveolar Hemorrhage (DAH)" ] 8 => array:2 [ "identificador" => "sec0025" "titulo" => "Conclusions and Outlooks" ] 9 => array:2 [ "identificador" => "sec0030" "titulo" => "Conflicts of Interest" ] 10 => array:1 [ "titulo" => "References" ] ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "fechaRecibido" => "2017-10-18" "fechaAceptado" => "2018-03-22" "PalabrasClave" => array:2 [ "en" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Keywords" "identificador" => "xpalclavsec1029557" "palabras" => array:5 [ 0 => "Systemic lupus erythematosus" 1 => "Lung condition" 2 => "Pleuropulmonary involvement" 3 => "Lupus pneumonitis" 4 => "Alveolar hemorrhage" ] ] ] "es" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Palabras clave" "identificador" => "xpalclavsec1029558" "palabras" => array:5 [ 0 => "Lupus eritematoso sistémico" 1 => "Afección pulmonar" 2 => "Afección pleuropulmonar" 3 => "Neumonitis lúpica" 4 => "Hemorragia alveolar" ] ] ] ] "tieneResumen" => true "resumen" => array:2 [ "en" => array:2 [ "titulo" => "Abstract" "resumen" => "<span id="abst0005" class="elsevierStyleSection elsevierViewall"><p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Systemic lupus erythematosus is the diffuse autoimmune connective tissue disease that most frequently involves pulmonary involvement, affecting 20% of 90% of the patients. The percentage varies depending on the defining criteria (symptoms, pulmonary tests or histopathological studies). At least once during the disease course, 50% of those affected have pleural and/or pulmonary manifestations, which are associated with higher morbidity and mortality. Pulmonary involvement has no correlation with lupus activity biomarkers, and it is necessary to rule out infectious processes in the initial approach. Bacterial infection is most frequently the cause of lung involvement in lupus and is one of the most important causes of death. Pulmonary involvement is considered to be primary when it is associated with disease activity, and secondary when other causes participate. Drugs have been reported to be associated with pulmonary damage, including interstitial disease. The incidence of malignant lung diseases is increased in systemic lupus erythematosus. Treatment depends on the type and severity of pulmonary involvement.</p></span>" ] "es" => array:2 [ "titulo" => "Resumen" "resumen" => "<span id="abst0010" class="elsevierStyleSection elsevierViewall"><p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">El lupus eritematoso sistémico (LES) es la enfermedad autoinmune difusa del tejido conectivo que con mayor frecuencia afecta al pulmón, la cual oscila del 20 al 90%, porcentaje variable en función de los criterios empleados en las cohortes estudiadas (sintomatología hasta histopatología). Más del 50% de los pacientes presentan manifestaciones pleuropulmonares por lo menos una vez durante el curso de su enfermedad y tal afección se asocia a mayor mortalidad. Las anomalías pulmonares no correlacionan con marcadores séricos de actividad lúpica. Es prioritario descartar infección pulmonar en la evaluación inicial, ya que la afección parenquimatosa más frecuente es la infección bacteriana y constituye una de las principales causas de muerte. También se han descrito participación de agentes atípicos, que incluyen los que condicionan enfermedades granulomatosas y otros oportunistas. La afección pleuropulmonar en LES puede estar directamente asociada a LES o ser secundaria. Fármacos pueden ocasionar neumonitis e incluso progresión a enfermedad intersticial. Hay un incremento discreto en el riesgo de neoplasias pulmonares.</p></span>" ] ] "NotaPie" => array:1 [ 0 => array:2 [ "etiqueta" => "☆" "nota" => "<p class="elsevierStyleNotepara" id="npar0005">Please cite this article as: Aguilera-Pickens G, Abud-Mendoza C. Manifestaciones pulmonares en lupus eritematoso sistémico: afección pleural, neumonitis aguda, enfermedad intersticial crónica y hemorragia alveolar difusa. Reumatol Clin. 2018;14:294–300.</p>" ] ] "multimedia" => array:4 [ 0 => array:7 [ "identificador" => "fig0005" "etiqueta" => "Fig. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 587 "Ancho" => 1750 "Tamanyo" => 130639 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">A 22-year-old woman with a 3-year history of generalized lupus erythematosus characterized by skin and musculoskeletal manifestations. She presented with a 1-month history characterized by pleuritic-like pain and dyspnea. Plain chest radiography revealed radiopaque images that obliterated the costophrenic angles, compatible with pleural effusion. It was contended with and was subsequently attributed to the activity of her underlying disease.</p>" ] ] 1 => array:7 [ "identificador" => "fig0010" "etiqueta" => "Fig. 2" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr2.jpeg" "Alto" => 365 "Ancho" => 1750 "Tamanyo" => 70505 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0020" class="elsevierStyleSimplePara elsevierViewall">A 24-year-old woman with a 4-year history of generalized lupus erythematosus characterized predominantly by musculoskeletal and hematological manifestations (autoimmune hemolytic anemia). She came to the emergency department with a 10-day history consisting of dyspnea and dry cough and later on with hemoptysis on 6 occasions. At admission, she had tachycardia and hypoxemia. Computed tomography revealed predominantly bibasal ground glass. After an infectious process was ruled out, the possibility of lupus pneumonitis was considered. She received pulses of methylprednisolone and cyclophosphamide and improvement was achieved.</p>" ] ] 2 => array:7 [ "identificador" => "fig0015" "etiqueta" => "Fig. 3" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr3.jpeg" "Alto" => 774 "Ancho" => 750 "Tamanyo" => 57844 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0025" class="elsevierStyleSimplePara elsevierViewall">A 22-year-old man with a twin brother with systemic lupus erythematosus. Both showed evidence of Schnitzler syndrome (intermittent episodes of fever, urticaria, abdominal pain, angioedema, arthritis). He had a 2-month history of progressive dyspnea even on minimum exertion, polyarthritis, hypertension, mechanical edema and, on the preceding days, cough and increased dyspnea. Exploration revealed Chávez’ pulmonary complex and right basal condensation syndrome; radiograph showing evidence of pulmonary hypertension, 4 arches, right basal pneumonitis and homolateral effusion. He was diagnosed with lupus pneumonitis, which was managed with prednisone at 0.5<span class="elsevierStyleHsp" style=""></span>mg/kg body weight/day and cyclophosphamide, with a satisfactory response.</p>" ] ] 3 => array:7 [ "identificador" => "fig0020" "etiqueta" => "Fig. 4" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr4.jpeg" "Alto" => 737 "Ancho" => 750 "Tamanyo" => 52771 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0030" class="elsevierStyleSimplePara elsevierViewall">A 20-year-old woman with a 4-year history of systemic lupus erythematosus. She had necrotizing vasculitis in lower limbs, psychosis, erythema, photosensitivity, thrombocytopenia, lymphopenia, severe anemia, was positive for Venereal Disease Research Laboratory and had an antinuclear antibody titer of 1:640, homogeneous and peripheral. In recent months, she had developed progressive dyspnea even on minimum exertion; over the last few days, she had increased cough, dyspnea and hemoptysis. Her hemoglobin level was 3<span class="elsevierStyleHsp" style=""></span>g, and she had hypoxemia, nephrotic proteinuria and telescoped sediment. The chest radiograph shows alveolar images compatible with diffuse alveolar hemorrhage. The patient received 1<span class="elsevierStyleHsp" style=""></span>g methylprednisolone for 3 days and cyclophosphamide and the response was satisfactory.</p>" ] ] ] "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0015" "bibliografiaReferencia" => array:86 [ 0 => array:3 [ "identificador" => "bib0435" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Pulmonary involvement of systemic lupus erythematosus: analysis of 90 necropsies" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "S.A. Quadrelli" 1 => "C. Alvarez" 2 => "S.C. Arce" 3 => "L. Paz" 4 => "J. Sarano" 5 => "E.M. Sobrino" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1177/0961203309106601" "Revista" => array:6 [ "tituloSerie" => "Lupus" "fecha" => "2009" "volumen" => "18" "paginaInicial" => "1053" "paginaFinal" => "1060" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19762378" "web" => "Medline" ] ] ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0440" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Respiratory manifestations of systemic lupus erythematosus: old and new concepts" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "J.M. Pego-Reigosa" 1 => "D.A. Medeiros" 2 => "D.A. Isenberg" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.berh.2009.01.002" "Revista" => array:6 [ "tituloSerie" => "Best Pract Res Clin Rheumatol" "fecha" => "2009" "volumen" => "23" "paginaInicial" => "469" "paginaFinal" => "480" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19591778" "web" => "Medline" ] ] ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0445" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Pulmonary manifestations of systemic lupus erythematosus" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "D.L. Kamen" 1 => "C. Strange" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.ccm.2010.05.001" "Revista" => array:6 [ "tituloSerie" => "Clin Chest Med" "fecha" => "2010" "volumen" => "31" "paginaInicial" => "479" "paginaFinal" => "488" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/20692540" "web" => "Medline" ] ] ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0450" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Dyspnea in ambulatory patients with SLE: prevalence, severity, and correlation with incremental exercise testing" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "D.B. Hellman" 1 => "C.M. Kirsch" 2 => "Q. Whiting-O’Keefe" 3 => "J. Simonson" 4 => "N.B. Schiller" 5 => "M. Petri" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "J Rheumatol" "fecha" => "1995" "volumen" => "22" "paginaInicial" => "455" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/7783061" "web" => "Medline" ] ] ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0455" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "High-resolution chest CT in systemic lupus erythematosus" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "H.M. Fenlon" 1 => "M. Doran" 2 => "S.M. Sant" 3 => "E. Breatnach" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Am J Roentogenol" "fecha" => "1996" "volumen" => "166" "paginaInicial" => "301" "paginaFinal" => "307" ] ] ] ] ] ] 5 => array:3 [ "identificador" => "bib0460" "etiqueta" => "6" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Pulmonary diffusion capacity in patients with systemic lupus erythematosus" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "M. Nakano" 1 => "H. Hasegawa" 2 => "T. Takada" 3 => "S. Ito" 4 => "Y. Muramatsu" 5 => "M. Satoh" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Respirology" "fecha" => "2002" "volumen" => "7" "paginaInicial" => "45" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/11896900" "web" => "Medline" ] ] ] ] ] ] ] ] 6 => array:3 [ "identificador" => "bib0465" "etiqueta" => "7" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "A clinical study of pulmonary manifestations in systemic lupus erythematosus with special reference to CT findings" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "S. Kakati" 1 => "B. Doley" 2 => "P. Dihingia" 3 => "U. Pegu" 4 => "S. Pal" 5 => "U.J. Deka" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Indian J Rheumatol" "fecha" => "2008" "volumen" => "2" "paginaInicial" => "133" "paginaFinal" => "136" "itemHostRev" => array:3 [ "pii" => "S0015028203022544" "estado" => "S300" "issn" => "00150282" ] ] ] ] ] ] ] 7 => array:3 [ "identificador" => "bib0470" "etiqueta" => "8" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Pleuropulmonary involvement in patients with systemic lupus erythematosus from a Latin American inception cohort (GLADEL)" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "M.J. Haye Salinas" 1 => "F. Caeiro" 2 => "V. Saurit" 3 => "A. Alvarellos" 4 => "D. Wojdyla" 5 => "H.R. Scherbarth" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1177/0961203317699284" "Revista" => array:7 [ "tituloSerie" => "Lupus" "fecha" => "2017" "volumen" => "26" "paginaInicial" => "1368" "paginaFinal" => "1377" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/28420071" "web" => "Medline" ] ] "itemHostRev" => array:3 [ "pii" => "S0015028217302145" "estado" => "S300" "issn" => "00150282" ] ] ] ] ] ] ] 8 => array:3 [ "identificador" => "bib0475" "etiqueta" => "9" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Mortality in systemic lupus erythematosus" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "S. Bernatsky" 1 => "J.F. Boivin" 2 => "L. Joseph" 3 => "S. Manzi" 4 => "E. Ginzler" 5 => "D.D. Gladman" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1002/art.21955" "Revista" => array:6 [ "tituloSerie" => "Arthritis Rheum" "fecha" => "2006" "volumen" => "54" "paginaInicial" => "2550" "paginaFinal" => "2557" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16868977" "web" => "Medline" ] ] ] ] ] ] ] ] 9 => array:3 [ "identificador" => "bib0480" "etiqueta" => "10" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Clinical and genetic risk factors for pneumonia in systemic lupus erythematosus" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "B.W. Kinder" 1 => "M.M. Freemer" 2 => "T.E. King Jr." 3 => "R.F. Lum" 4 => "J. Nititham" 5 => "K. Taylor" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1002/art.22804" "Revista" => array:6 [ "tituloSerie" => "Arthritis Rheum" "fecha" => "2007" "volumen" => "56" "paginaInicial" => "2679" "paginaFinal" => "2686" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17665457" "web" => "Medline" ] ] ] ] ] ] ] ] 10 => array:3 [ "identificador" => "bib0485" "etiqueta" => "11" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Infections and SLE" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "G. Zandman-Goddard" 1 => "Y. Shoenfeld" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1080/08916930500285352" "Revista" => array:7 [ "tituloSerie" => "Autoimmunity" "fecha" => "2005" "volumen" => "38" "paginaInicial" => "473" "paginaFinal" => "485" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16373252" "web" => "Medline" ] ] "itemHostRev" => array:3 [ "pii" => "S001502821202540X" "estado" => "S300" "issn" => "00150282" ] ] ] ] ] ] ] 11 => array:3 [ "identificador" => "bib0490" "etiqueta" => "12" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Pulmonary manifestations in systemic lupus erythematosus: association with disease activity" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "O.S. Alamoudi" 1 => "S.M. Attar" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/resp.12473" "Revista" => array:7 [ "tituloSerie" => "Respirology" "fecha" => "2015" "volumen" => "20" "paginaInicial" => "474" "paginaFinal" => "480" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25639532" "web" => "Medline" ] ] "itemHostRev" => array:3 [ "pii" => "S0002937807023423" "estado" => "S300" "issn" => "00029378" ] ] ] ] ] ] ] 12 => array:3 [ "identificador" => "bib0495" "etiqueta" => "13" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Prevalence and risk factors for pulmonary arterial hypertension in patients with lupus" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "A. Prabu" 1 => "K. Patel" 2 => "C.S. Yee" 3 => "P. Nightingale" 4 => "R.D. Situnayake" 5 => "D.R. Thickett" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Rheumatology (Oxford)" "fecha" => "2009" "volumen" => "48" "paginaInicial" => "1506" "paginaFinal" => "1511" ] ] ] ] ] ] 13 => array:3 [ "identificador" => "bib0500" "etiqueta" => "14" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Atteinte respiratoire au cours du lupus érythémateux systémique" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "D. Carmier" 1 => "S. Marchand-Adam" 2 => "P. Diot" 3 => "E. Diot" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Rev Mal Respir" "fecha" => "2008" "volumen" => "25" "paginaInicial" => "1289" "paginaFinal" => "1303" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19107019" "web" => "Medline" ] ] ] ] ] ] ] ] 14 => array:3 [ "identificador" => "bib0505" "etiqueta" => "15" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Etiologies and outcomes of pleural effusions in patients with systemic lupus erythematosus" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "N. Palavutitotai" 1 => "T. Buppajarntham" 2 => "W. Katchamart" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "J Clin Rheumatol" "fecha" => "2014" "volumen" => "8" "paginaInicial" => "418" "paginaFinal" => "421" ] ] ] ] ] ] 15 => array:3 [ "identificador" => "bib0510" "etiqueta" => "16" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Pleuropulmonary manifestations of systemic lupus erythematosus" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "M.P. Keane" 1 => "J.P. Lynch 3rd" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Thorax" "fecha" => "2000" "volumen" => "55" "paginaInicial" => "159" "paginaFinal" => "166" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/10639536" "web" => "Medline" ] ] ] ] ] ] ] ] 16 => array:3 [ "identificador" => "bib0515" "etiqueta" => "17" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Usefulness of pleural effusion antinuclear antibodies in the diagnosis of lupus pleuritis" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "C. Toworakul" 1 => "N. Kasitanon" 2 => "W. Sukitawut" 3 => "R. Wichinun" 4 => "W. Louthrenoo" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1177/0961203311402531" "Revista" => array:6 [ "tituloSerie" => "Lupus" "fecha" => "2011" "volumen" => "20" "paginaInicial" => "1042" "paginaFinal" => "1046" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 17 => array:3 [ "identificador" => "bib0520" "etiqueta" => "18" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Characteristics of pleural effusions in systemic lupus erythematosus: differential diagnosis of lupus pleuritis" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ …5] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1177/0961203314555171" "Revista" => array:6 [ "tituloSerie" => "Lupus" "fecha" => "2015" "volumen" => "24" "paginaInicial" => "321" "paginaFinal" => "326" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 18 => array:3 [ "identificador" => "bib0525" "etiqueta" => "19" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Fibrothorax and severe lung restriction secondary to lupus pleuritis and its successful treatment by pleurectomy" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ …3] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1155/2002/740878" "Revista" => array:5 [ "tituloSerie" => "Can Respir J" "fecha" => "2002" "volumen" => "9" "paginaInicial" => "335" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 19 => array:3 [ "identificador" => "bib0530" "etiqueta" => "20" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Thoracic involvement of systemic lupus erythematosus: clinical, pathologic, and radiologic findings" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ …6] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "J Comput Assist Tomogr" "fecha" => "2000" "volumen" => "24" "paginaInicial" => "9" "paginaFinal" => "18" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 20 => array:3 [ "identificador" => "bib0535" "etiqueta" => "21" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Acute granulomatous lupus pneumonitis: the first case report" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ …4] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1177/0961203306076222" "Revista" => array:6 [ "tituloSerie" => "Lupus" "fecha" => "2007" "volumen" => "16" "paginaInicial" => "201" "paginaFinal" => "204" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 21 => array:3 [ "identificador" => "bib0540" "etiqueta" => "22" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Non-invasive ventilation in patients with acute lupus pneumonitis: a case report and review of literature" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ …2] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.4103/0970-2113.99115" "Revista" => array:6 [ "tituloSerie" => "Lung India" "fecha" => "2012" "volumen" => "29" "paginaInicial" => "270" "paginaFinal" => "272" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 22 => array:3 [ "identificador" => "bib0545" "etiqueta" => "23" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Bilateral acute lupus pneumonitis in a case of rhupus syndrome" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ …2] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.4103/0970-2113.99119" "Revista" => array:6 [ "tituloSerie" => "Lung India" "fecha" => "2012" "volumen" => "29" "paginaInicial" => "280" "paginaFinal" => "282" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 23 => array:3 [ "identificador" => "bib0550" "etiqueta" => "24" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Acute lupus pneumonitis-case report and literature review" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ …6] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:7 [ "tituloSerie" => "Pneumonol Alergol Pol" "fecha" => "2013" "volumen" => "81" "paginaInicial" => "460" "paginaFinal" => "467" "link" => array:1 [ 0 => array:2 [ …2] ] "itemHostRev" => array:3 [ "pii" => "S0015028206047030" "estado" => "S300" "issn" => "00150282" ] ] ] ] ] ] ] 24 => array:3 [ "identificador" => "bib0555" "etiqueta" => "25" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Systemic lupus erythematosus presenting as acute lupus pneumonitis in a young female" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ …4] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.4103/0022-3859.150902" "Revista" => array:6 [ "tituloSerie" => "J Postgrad Med" "fecha" => "2015" "volumen" => "61" "paginaInicial" => "129" "paginaFinal" => "130" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 25 => array:3 [ "identificador" => "bib0560" "etiqueta" => "26" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Interstitial lung disease in systemic lupus erythematosus" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ …2] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:7 [ "tituloSerie" => "Curr Opin Pulm Med" "fecha" => "2000" "volumen" => "6" "paginaInicial" => "424" "paginaFinal" => "429" "link" => array:1 [ 0 => array:2 [ …2] ] "itemHostRev" => array:3 [ "pii" => "S001502820701360X" "estado" => "S300" "issn" => "00150282" ] ] ] ] ] ] ] 26 => array:3 [ "identificador" => "bib0565" "etiqueta" => "27" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The respiratory system in connective tissue disorders" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ …1] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/j.1398-9995.2005.00761.x" "Revista" => array:6 [ "tituloSerie" => "Allergy" "fecha" => "2005" "volumen" => "60" "paginaInicial" => "715" "paginaFinal" => "734" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 27 => array:3 [ "identificador" => "bib0570" "etiqueta" => "28" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Lupus pneumonitis as the initial presentation of systemic lupus erythematosus: case series from a single institution" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ …3] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1177/0961203316646461" "Revista" => array:6 [ "tituloSerie" => "Lupus" "fecha" => "2016" "volumen" => "25" "paginaInicial" => "1485" "paginaFinal" => "1490" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 28 => array:3 [ "identificador" => "bib0575" "etiqueta" => "29" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Acute respiratory distress syndrome in a pregnant woman with systemic lupus erythematosus: a case report" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ …5] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1177/0961203314548713" "Revista" => array:6 [ "tituloSerie" => "Lupus" "fecha" => "2014" "volumen" => "23" "paginaInicial" => "1528" "paginaFinal" => "1532" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 29 => array:3 [ "identificador" => "bib0580" "etiqueta" => "30" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Pneumonitis in a lupus twin pregnancy: a case report" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ …5] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1177/096120339600500210" "Revista" => array:6 [ "tituloSerie" => "Lupus" "fecha" => "1996" "volumen" => "5" "paginaInicial" => "146" "paginaFinal" => "148" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 30 => array:3 [ "identificador" => "bib0585" "etiqueta" => "31" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Fatal lupus pleuritis presenting in pregnancy. A case report" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ …4] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "J Reprod Med" "fecha" => "1996" "volumen" => "41" "paginaInicial" => "537" "paginaFinal" => "540" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 31 => array:3 [ "identificador" => "bib0590" "etiqueta" => "32" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Intravenous immunoglobulin therapy of lupus pneumonitis" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ …4] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Indian J Pediatr" "fecha" => "2007" "volumen" => "74" "paginaInicial" => "1032" "paginaFinal" => "1033" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 32 => array:3 [ "identificador" => "bib0595" "etiqueta" => "33" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Rituximab use in systemic lupus erythematosus pneumonitis and a review of current reports" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ …6] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/j.1445-5994.2006.01055.x" "Revista" => array:6 [ "tituloSerie" => "Intern Med J" "fecha" => "2006" "volumen" => "36" "paginaInicial" => "260" "paginaFinal" => "262" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 33 => array:3 [ "identificador" => "bib0600" "etiqueta" => "34" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Immunogenicity and safety of influenza vaccination in systemic lupus erythematosus patients compared with healthy controls: a meta-analysis" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ …6] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1371/journal.pone.0147856" "Revista" => array:5 [ "tituloSerie" => "PLOS ONE" "fecha" => "2016" "volumen" => "11" "paginaInicial" => "e0147856" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 34 => array:3 [ "identificador" => "bib0605" "etiqueta" => "35" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Pleural and pulmonary involvement in systemic lupus erythematosus" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ …2] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Presse Méd" "fecha" => "2011" "volumen" => "40" "paginaInicial" => "e41" "paginaFinal" => "e51" ] ] ] ] ] ] 35 => array:3 [ "identificador" => "bib0610" "etiqueta" => "36" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Detectionof pulmonary involvement in lupus patients with and without clinical pulmonary symptoms" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ …4] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Egypt J Chest Dis Tuberc" "fecha" => "2014" "volumen" => "63" "paginaInicial" => "463" "paginaFinal" => "469" ] ] ] ] ] ] 36 => array:3 [ "identificador" => "bib0615" "etiqueta" => "37" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Discrete lung involvement in systemic lupus erythematosus: CT assessment" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ …6] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1148/radiology.196.3.7644652" "Revista" => array:6 [ "tituloSerie" => "Radiology" "fecha" => "1995" "volumen" => "196" "paginaInicial" => "835" "paginaFinal" => "840" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 37 => array:3 [ "identificador" => "bib0620" "etiqueta" => "38" "referencia" => array:1 [ 0 => array:3 [ "comentario" => "352, h6819" "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Management of interstitial lung disease associated with connective tissue disease" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ …2] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:4 [ "tituloSerie" => "BMJ" "fecha" => "2016" "volumen" => "24" "itemHostRev" => array:3 [ "pii" => "S0015028211027087" "estado" => "S300" "issn" => "00150282" ] ] ] ] ] ] ] 38 => array:3 [ "identificador" => "bib0625" "etiqueta" => "39" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Thoracic manifestations of connective tissue diseases" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ …6] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1067/j.cpradiol.2014.07.002" "Revista" => array:6 [ "tituloSerie" => "Curr Probl Diagn Radiol" "fecha" => "2015" "volumen" => "44" "paginaInicial" => "47" "paginaFinal" => "59" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 39 => array:3 [ "identificador" => "bib0630" "etiqueta" => "40" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Interstitial pneumonitis in antinuclear antibodynegative systemic lupus erythematosus: a new clinical manifestation and possible association with anti-Ro (SS-A) antibodies" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ …2] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Arthritis Rheum" "fecha" => "1988" "volumen" => "31" "paginaInicial" => "545" "paginaFinal" => "548" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 40 => array:3 [ "identificador" => "bib0635" "etiqueta" => "41" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Lymphoid interstitial pneumonia: clinical features, associations and prognosis" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ …5] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1183/09031936.06.00076705" "Revista" => array:6 [ "tituloSerie" => "Eur Respir J" "fecha" => "2006" "volumen" => "28" "paginaInicial" => "364" "paginaFinal" => "369" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 41 => array:3 [ "identificador" => "bib0640" "etiqueta" => "42" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Lymphocytic interstitial pneumonia as a manifestation of SLE and secondary Sjögren's syndrome" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ …2] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:2 [ "tituloSerie" => "BMJ Case Rep" "fecha" => "2013" ] ] ] ] ] ] 42 => array:3 [ "identificador" => "bib0645" "etiqueta" => "43" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Bronchoalveolar lavage (BAL) in newly diagnosed patients with collagen vascular diseases" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ …5] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Indian J Chest Dis Allied Sci" "fecha" => "1998" "volumen" => "40" "paginaInicial" => "243" "paginaFinal" => "250" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 43 => array:3 [ "identificador" => "bib0650" "etiqueta" => "44" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Quismorio: a long-term study of interstitial lung disease in systemic lupus erythematosus" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ …2] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Semin Arthritis Rheum" "fecha" => "1990" "volumen" => "20" "paginaInicial" => "48" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 44 => array:3 [ "identificador" => "bib0655" "etiqueta" => "45" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Immunosuppression for connective tissue disease-related pulmonary disease" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ …1] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1055/s-0034-1371531" "Revista" => array:6 [ "tituloSerie" => "Semin Respir Crit Care Med" "fecha" => "2014" "volumen" => "35" "paginaInicial" => "265" "paginaFinal" => "273" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 45 => array:3 [ "identificador" => "bib0660" "etiqueta" => "46" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Successful experience of rituximab therapy for systemic sclerosis-associated interstitial lung disease with concomitant systemic lupus erythematosus" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ …6] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/1346-8138.12461" "Revista" => array:6 [ "tituloSerie" => "J Dermatol" "fecha" => "2014" "volumen" => "41" "paginaInicial" => "418" "paginaFinal" => "420" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 46 => array:3 [ "identificador" => "bib0665" "etiqueta" => "47" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Treatment of lupus interstitial lung disease with intravenous cyclophosphamide" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ …2] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Arthritis Rheum" "fecha" => "1994" "volumen" => "37" "paginaInicial" => "428" "paginaFinal" => "431" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 47 => array:3 [ "identificador" => "bib0670" "etiqueta" => "48" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Successful treatment of interstitial lung disease in systemic lupus erythematosus with methotrexate" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ …2] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "J Rhuematol" "fecha" => "1995" "volumen" => "22" "paginaInicial" => "967" "paginaFinal" => "969" ] ] ] ] ] ] 48 => array:3 [ "identificador" => "bib0675" "etiqueta" => "49" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Serial pulmonary function testing in patients with systemic lupus erythematosus" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ …5] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Chest" "fecha" => "1988" "volumen" => "94" "paginaInicial" => "129" "paginaFinal" => "132" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 49 => array:3 [ "identificador" => "bib0680" "etiqueta" => "50" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Variations in histological patterns of interstitial pneumonia between connective tissue disorders and their relationship to prognosis" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ …6] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/j.1365-2559.2004.01896.x" "Revista" => array:6 [ "tituloSerie" => "Histopathology" "fecha" => "2004" "volumen" => "44" "paginaInicial" => "585" "paginaFinal" => "596" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 50 => array:3 [ "identificador" => "bib0685" "etiqueta" => "51" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Pulmonary hemorrhage in systemic lupus erythematosus" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ …5] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Semin Arthritis Rheum" "fecha" => "2004" "volumen" => "33" "paginaInicial" => "414" "paginaFinal" => "421" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 51 => array:3 [ "identificador" => "bib0690" "etiqueta" => "52" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Diffuse alveolar hemorrhage in Colombian patients with systemic lupus erythematosus" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ …4] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s10067-007-0576-3" "Revista" => array:6 [ "tituloSerie" => "Clin Rheumatol" "fecha" => "2007" "volumen" => "26" "paginaInicial" => "1947" "paginaFinal" => "1949" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 52 => array:3 [ "identificador" => "bib0695" "etiqueta" => "53" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "High prevalence of infections in patients with systemic lupus erythematosus and pulmonary haemorrhage" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ …6] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1177/0961203307086930" "Revista" => array:6 [ "tituloSerie" => "Lupus" "fecha" => "2008" "volumen" => "17" "paginaInicial" => "295" "paginaFinal" => "299" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 53 => array:3 [ "identificador" => "bib0700" "etiqueta" => "54" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Diffuse alveolar hemorrhage in systemic lupus erythematosus: a retrospective study in China" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ …6] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1177/0961203310373106" "Revista" => array:7 [ "tituloSerie" => "Lupus" "fecha" => "2010" "volumen" => "19" "paginaInicial" => "1326" "paginaFinal" => "13230" "link" => array:1 [ 0 => array:2 [ …2] ] "itemHostRev" => array:3 [ "pii" => "S0015028216630121" "estado" => "S300" "issn" => "00150282" ] ] ] ] ] ] ] 54 => array:3 [ "identificador" => "bib0705" "etiqueta" => "55" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Predictors of mortality in diffuse alveolar haemorrhage associated with systemic lupus erythematosus" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ …2] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1177/0961203310392430" "Revista" => array:7 [ "tituloSerie" => "Lupus" "fecha" => "2011" "volumen" => "20" "paginaInicial" => "568" "paginaFinal" => "574" "link" => array:1 [ 0 => array:2 [ …2] ] "itemHostRev" => array:3 [ "pii" => "S0015028202032491" "estado" => "S300" "issn" => "00150282" ] ] ] ] ] ] ] 55 => array:3 [ "identificador" => "bib0710" "etiqueta" => "56" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Diffuse alveolar hemorrhage in systemic lupus erythematosus: risk factors and clinical outcome: results from affiliated hospitals of Catholic University of Korea" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ …6] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1177/0961203310381511" "Revista" => array:6 [ "tituloSerie" => "Lupus" "fecha" => "2011" "volumen" => "20" "paginaInicial" => "102" "paginaFinal" => "107" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 56 => array:3 [ "identificador" => "bib0715" "etiqueta" => "57" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Alveolar hemorrhage: distinct features of juvenile and adult onset systemic lupus erythematosus" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ …6] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1177/0961203312441047" "Revista" => array:6 [ "tituloSerie" => "Lupus" "fecha" => "2012" "volumen" => "21" "paginaInicial" => "872" "paginaFinal" => "877" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 57 => array:3 [ "identificador" => "bib0720" "etiqueta" => "58" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Alveolar hemorrhage in systemic lupus erythematosus: a cohort review" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ …6] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1177/0961203315605365" "Revista" => array:6 [ "tituloSerie" => "Lupus" "fecha" => "2016" "volumen" => "25" "paginaInicial" => "75" "paginaFinal" => "80" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 58 => array:3 [ "identificador" => "bib0725" "etiqueta" => "59" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Diffuse alveolar hemorrhage in patients with systemic lupus erythematosus. clinical manifestations, treatment, and prognosis" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ …2] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.reuma.2014.02.002" "Revista" => array:6 [ "tituloSerie" => "Reumatol Clin" "fecha" => "2014" "volumen" => "10" "paginaInicial" => "248" "paginaFinal" => "253" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 59 => array:3 [ "identificador" => "bib0730" "etiqueta" => "60" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Alveolar hemorrhage and renal microangiopathy in systemic lupus erythematosus" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ …4] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1043/0003-9985(2001)125<0475:AHARMI>2.0.CO;2" "Revista" => array:6 [ "tituloSerie" => "Arch Pathol Lab Med" "fecha" => "2001" "volumen" => "125" "paginaInicial" => "475" "paginaFinal" => "483" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 60 => array:3 [ "identificador" => "bib0735" "etiqueta" => "61" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The lung in systemic lupus erythematosus. Analysis of the pathologic changes in 120 patients" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ …3] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Am J Med" "fecha" => "1981" "volumen" => "71" "paginaInicial" => "791" "paginaFinal" => "798" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 61 => array:3 [ "identificador" => "bib0740" "etiqueta" => "62" "referencia" => array:1 [ 0 => array:3 [ "comentario" => "1936282" "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Diffuse alveolar hemorrhage in systemic lupus erythematosus: histopathologic features and clinical correlations" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ …3] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:2 [ "tituloSerie" => "Case Rep Pathol" "fecha" => "2017" ] ] ] ] ] ] 62 => array:3 [ "identificador" => "bib0745" "etiqueta" => "63" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Diffuse alveolar hemorrhage and systemic lupus erythematosus. Clinical presentation, histology, survival and outcome" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ …4] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Medicine (Baltimore)" "fecha" => "1997" "volumen" => "76" "paginaInicial" => "192" "paginaFinal" => "222" ] ] ] ] ] ] 63 => array:3 [ "identificador" => "bib0750" "etiqueta" => "64" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Alveolar hemorrhage in systemic lupus erythematosus. Presentation and management" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ …3] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Chest" "fecha" => "2000" "volumen" => "118" "paginaInicial" => "1083" "paginaFinal" => "1090" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 64 => array:3 [ "identificador" => "bib0755" "etiqueta" => "65" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Update on diffuse alveolar hemorrhage and pulmonary vasculitis" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ …4] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Immunol Allergy Clin N Am" "fecha" => "2012" "volumen" => "32" "paginaInicial" => "587" "paginaFinal" => "600" ] ] ] ] ] ] 65 => array:3 [ "identificador" => "bib0760" "etiqueta" => "66" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Microangiitis in lupus induced pulmonary hemorrhage" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ …2] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Am J Clin Pathol" "fecha" => "1986" "volumen" => "85" "paginaInicial" => "552" "paginaFinal" => "556" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 66 => array:3 [ "identificador" => "bib0765" "etiqueta" => "67" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Pulmonary alveolar hemorrhage in systemic lupus erythematosus" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ …4] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Semin Arthritis Rheum" "fecha" => "1993" "volumen" => "23" "paginaInicial" => "8" "paginaFinal" => "15" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 67 => array:3 [ "identificador" => "bib0770" "etiqueta" => "68" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Factors associated with mortality and infections in patients with systemic lupus erythematosus with diffuse alveolar hemorrhage" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:7 [ …7] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:4 [ "tituloSerie" => "J Rheumatol" "fecha" => "2014" "volumen" => "41" "paginaInicial" => "8" ] ] ] ] ] ] 68 => array:3 [ "identificador" => "bib0775" "etiqueta" => "69" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Clinical characteristics and outcomes of diffuse alveolar hemorrhage in patients with systemic lupus erythematosus" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ …6] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.semarthrit.2016.09.004" "Revista" => array:7 [ "tituloSerie" => "Semin Arthritis Rheum" "fecha" => "2017" "volumen" => "46" "paginaInicial" => "782" "paginaFinal" => "787" "link" => array:1 [ 0 => array:2 [ …2] ] "itemHostRev" => array:3 [ "pii" => "S0015028205036046" "estado" => "S300" "issn" => "00150282" ] ] ] ] ] ] ] 69 => array:3 [ "identificador" => "bib0780" "etiqueta" => "70" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Pulmonary hemorrhage in systemic lupus erythematosus" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ …5] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1177/096120339700600506" "Revista" => array:6 [ "tituloSerie" => "Lupus" "fecha" => "1997" "volumen" => "6" "paginaInicial" => "445" "paginaFinal" => "448" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 70 => array:3 [ "identificador" => "bib0785" "etiqueta" => "71" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Clinical and immunological effects of rituximab in patients with lupus nephritis refractory to conventional therapy: a pilot study" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ …6] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1186/ar1954" "Revista" => array:5 [ "tituloSerie" => "Arthritis Res Ther" "fecha" => "2006" "volumen" => "8" "paginaInicial" => "R83" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 71 => array:3 [ "identificador" => "bib0790" "etiqueta" => "72" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Successful early rituximab treatment in a case of systemic lupus erythematosus with potentially fatal diffuse alveolar hemorrhage" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ …6] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1159/000369038" "Revista" => array:6 [ "tituloSerie" => "Respiration" "fecha" => "2015" "volumen" => "89" "paginaInicial" => "62" "paginaFinal" => "65" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 72 => array:3 [ "identificador" => "bib0795" "etiqueta" => "73" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Rituximab: an emerging treatment for recurrent diffuse alveolar hemorrhage in systemic lupus erythematosus" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ …4] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1177/0961203314564235" "Revista" => array:6 [ "tituloSerie" => "Lupus" "fecha" => "2015" "volumen" => "24" "paginaInicial" => "756" "paginaFinal" => "759" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 73 => array:3 [ "identificador" => "bib0800" "etiqueta" => "74" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Severe multiorganic flare of systemic lupus erythematosus successfully treated with rituximab and cyclophosphamide avoiding high doses of prednisone" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ …4] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1177/0961203314520842" "Revista" => array:6 [ "tituloSerie" => "Lupus" "fecha" => "2014" "volumen" => "23" "paginaInicial" => "323" "paginaFinal" => "326" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 74 => array:3 [ "identificador" => "bib0805" "etiqueta" => "75" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Recurrent diffuse alveolar haemorrhage in a patient with systemic lupus erythematosus: long-term benefit of rituximab" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ …2] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1177/0961203312444171" "Revista" => array:6 [ "tituloSerie" => "Lupus" "fecha" => "2012" "volumen" => "21" "paginaInicial" => "1124" "paginaFinal" => "1127" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 75 => array:3 [ "identificador" => "bib0810" "etiqueta" => "76" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Successful rituximab therapy in a lupus patient with diffuse alveolar haemorrhage" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ …6] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1177/0961203310386276" "Revista" => array:6 [ "tituloSerie" => "Lupus" "fecha" => "2011" "volumen" => "20" "paginaInicial" => "656" "paginaFinal" => "659" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 76 => array:3 [ "identificador" => "bib0815" "etiqueta" => "77" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Rituximab as early therapy for pulmonary haemorrhage in systemic lupus erythematosus" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ …5] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1093/rheumatology/kep356" "Revista" => array:6 [ "tituloSerie" => "Rheumatology" "fecha" => "2010" "volumen" => "49" "paginaInicial" => "392" "paginaFinal" => "394" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 77 => array:3 [ "identificador" => "bib0820" "etiqueta" => "78" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Diffuse alveolar haemorrhage in a systemic lupus erythematosus patient successfully treated with rituximab: a case report" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ …6] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Neprhol Dial Transplant" "fecha" => "2008" "volumen" => "23" "paginaInicial" => "385" "paginaFinal" => "386" "itemHostRev" => array:3 [ "pii" => "S0015028216630947" "estado" => "S300" "issn" => "00150282" ] ] ] ] ] ] ] 78 => array:3 [ "identificador" => "bib0825" "etiqueta" => "79" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Mesenchymal stem cell transplantation for diffuse alveolar hemorrhage in SLE" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ …6] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1038/nrrheum.2010.80" "Revista" => array:6 [ "tituloSerie" => "Nat Rev Rheumatol" "fecha" => "2010" "volumen" => "6" "paginaInicial" => "486" "paginaFinal" => "489" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 79 => array:3 [ "identificador" => "bib0830" "etiqueta" => "80" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Allogeneic transplantation of umbilical cord-derived mesenchymal stem cells for diffuse alveolar hemorrhage in systemic lupus erythematosus" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ …6] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s10067-012-1943-2" "Revista" => array:6 [ "tituloSerie" => "Clin Rheumatol" "fecha" => "2012" "volumen" => "31" "paginaInicial" => "841" "paginaFinal" => "846" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 80 => array:3 [ "identificador" => "bib0835" "etiqueta" => "81" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Systemic lupus-induced diffuse alveolar hemorrhage treated with extracorporeal membrane oxygenation: a case report and review of the literature" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ …2] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1177/0885066612464335" "Revista" => array:6 [ "tituloSerie" => "J Intensive Care Med" "fecha" => "2014" "volumen" => "29" "paginaInicial" => "104" "paginaFinal" => "109" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 81 => array:3 [ "identificador" => "bib0840" "etiqueta" => "82" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Extracorporeal membrane oxygenation in diffuse alveolar hemorrhage secondary to systemic lupus erythematosus" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ …5] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.14740/jocmr1685w" "Revista" => array:6 [ "tituloSerie" => "J Clin Med Res" "fecha" => "2014" "volumen" => "6" "paginaInicial" => "145" "paginaFinal" => "148" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 82 => array:3 [ "identificador" => "bib0845" "etiqueta" => "83" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Alveolar hemorrhage secondary to generalized systemic lupus erythematosus treated with recombinant activated factor VII. Case report and literature review" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ …4] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Gac Med Mex" "fecha" => "2007" "volumen" => "143" "paginaInicial" => "83" "paginaFinal" => "86" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 83 => array:3 [ "identificador" => "bib0850" "etiqueta" => "84" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Treatment of diffuse alveolar hemorrhage secondary to lupus erythematosus with recombinant activated factor VII administered with a jet nebulizer" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ …5] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1186/s40560-014-0047-2" "Revista" => array:5 [ "tituloSerie" => "J Intensive Care" "fecha" => "2014" "volumen" => "2" "paginaInicial" => "47" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 84 => array:3 [ "identificador" => "bib0855" "etiqueta" => "85" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Use of activated factor VII in patients with diffuse alveolar hemorrhage: a 10 years institutional experience" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ …6] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s00408-015-9720-z" "Revista" => array:6 [ "tituloSerie" => "Lung" "fecha" => "2015" "volumen" => "193" "paginaInicial" => "375" "paginaFinal" => "379" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] 85 => array:3 [ "identificador" => "bib0860" "etiqueta" => "86" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Mycophenolate mofetil as a maintenance therapy for lupus-related diffuse alveolar hemorrhage: a case report" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ …3] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1177/0961203311411353" "Revista" => array:6 [ "tituloSerie" => "Lupus" "fecha" => "2011" "volumen" => "20" "paginaInicial" => "1551" "paginaFinal" => "1553" "link" => array:1 [ 0 => array:2 [ …2] ] ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/21735743/0000001400000005/v1_201810010939/S2173574318300728/v1_201810010939/en/main.assets" "Apartado" => array:4 [ "identificador" => "8383" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Review Article" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/21735743/0000001400000005/v1_201810010939/S2173574318300728/v1_201810010939/en/main.pdf?idApp=UINPBA00004M&text.app=https://reumatologiaclinica.org/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173574318300728?idApp=UINPBA00004M" ]
Year/Month | Html | Total | |
---|---|---|---|
2024 October | 260 | 145 | 405 |
2024 September | 286 | 123 | 409 |
2024 August | 308 | 151 | 459 |
2024 July | 379 | 171 | 550 |
2024 June | 363 | 178 | 541 |
2024 May | 417 | 139 | 556 |
2024 April | 369 | 149 | 518 |
2024 March | 2263 | 159 | 2422 |
2024 February | 369 | 150 | 519 |
2024 January | 480 | 141 | 621 |
2023 December | 441 | 106 | 547 |
2023 November | 436 | 173 | 609 |
2023 October | 534 | 124 | 658 |
2023 September | 495 | 125 | 620 |
2023 August | 516 | 126 | 642 |
2023 July | 338 | 95 | 433 |
2023 June | 414 | 91 | 505 |
2023 May | 387 | 95 | 482 |
2023 April | 326 | 99 | 425 |
2023 March | 459 | 116 | 575 |
2023 February | 388 | 115 | 503 |
2023 January | 371 | 89 | 460 |
2022 December | 483 | 114 | 597 |
2022 November | 482 | 151 | 633 |
2022 October | 398 | 120 | 518 |
2022 September | 459 | 192 | 651 |
2022 August | 380 | 158 | 538 |
2022 July | 353 | 169 | 522 |
2022 June | 425 | 134 | 559 |
2022 May | 529 | 153 | 682 |
2022 April | 577 | 156 | 733 |
2022 March | 726 | 170 | 896 |
2022 February | 648 | 145 | 793 |
2022 January | 536 | 200 | 736 |
2021 December | 377 | 146 | 523 |
2021 November | 324 | 135 | 459 |
2021 October | 274 | 189 | 463 |
2021 September | 308 | 126 | 434 |
2021 August | 255 | 149 | 404 |
2021 July | 279 | 75 | 354 |
2021 June | 322 | 117 | 439 |
2021 May | 364 | 116 | 480 |
2021 April | 2001 | 290 | 2291 |
2021 March | 1085 | 262 | 1347 |
2021 February | 545 | 172 | 717 |
2021 January | 579 | 179 | 758 |
2020 December | 536 | 162 | 698 |
2020 November | 745 | 98 | 843 |
2020 October | 414 | 107 | 521 |
2020 September | 834 | 128 | 962 |
2020 August | 681 | 124 | 805 |
2020 July | 347 | 203 | 550 |
2020 June | 295 | 123 | 418 |
2020 May | 284 | 63 | 347 |
2020 April | 189 | 98 | 287 |
2020 March | 66 | 12 | 78 |
2019 May | 0 | 2 | 2 |